Simultaneously, it suppresses bile acid synthase (e.g., Cyp7b1) expression and interferes with the farnesoid X receptor (FXR) pathway, thus altering the bile salt composition in a manner that favors gallstone formation (49). The gene discussed is NR1H4; the disease is gallstones.